Christophe Pialot

Christophe Pialot appears in our data through filings on Bioservo Technologies Aktiebolag shares, published by Finansinspektionen. Between 25 March 2021 and 8 December 2023, the trades on record add up to 4 filings.

In open-market terms, that means 3 purchases worth €5,689 on one side and 1 sale worth €70 on the other. Purchases outweigh sales by €5,619. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2023: no purchases and 1 sale on the market.

A typical purchase (the median) is worth €1,097. Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 8 December 2023, reports an open-market sale of €70 in Bioservo Technologies Aktiebolag. The latest purchase dates back some time: it was published 1,956 days ago, on 1 July 2021. The median gap between trade and publication is zero days: most filings appear on the same day. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.